Invention Grant
- Patent Title: Substituted tricyclic compounds as FGFR inhibitors
-
Application No.: US13915775Application Date: 2013-06-12
-
Publication No.: US09611267B2Publication Date: 2017-04-04
- Inventor: Liangxing Wu , Colin Zhang , Chunhong He , Liang Lu , Wenqing Yao
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/14
- IPC: C07D471/14 ; C07D471/20 ; C07D471/22 ; C07D495/14 ; C07D498/14 ; C07D498/22 ; C07D491/22
Abstract:
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Public/Granted literature
- US20130338134A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS Public/Granted day:2013-12-19
Information query
